Moreover, the analysis revealed that N-acetylglutamate synthase is causally associated with ER+ breast cancer, identified as a risk factor (IVW, p=0.025, OR = 1.060, 95% CI: 1.008–1.116). Here, NAGS is linked to breast cancer.